Therapy Areas: Diabetes
Sterotherapeutics launches Phase 2 clinical trial of ST-002 for Cushing's Syndrome
25 February 2025 - US biopharmaceutical company Sterotherapeutics announced on Monday that it has launched a Phase 2 clinical trial of ST-002, a novel drug candidate for patients with Cushing's S...
FDA accepts Alvotech and Teva's application for Eylea biosimilar
18 February 2025 - Biotech company Alvotech S.A. (NASDAQ:ALVO) and Teva Pharmaceuticals, a US affiliate of Israel-based pharmaceutical company Teva Pharmaceutical Industries Ltd (NYSE:TEVA) (TASE:TEVA...
Owens & Minor launches ByramConnect digital health platform for diabetes management
11 February 2025 - Healthcare solutions company Owens & Minor Inc (NYSE:OMI) on Tuesday introduced ByramConnect, a digital health platform designed to support Byram Healthcare customers managing d...
NLS Pharmaceutics and Kadimastem plan multi-target approach to diabetes
11 February 2025 - Swiss clinical-stage biopharmaceutical company NLS Pharmaceutics Ltd (Nasdaq: NLSP) and Kadimastem Ltd (TASE: KDST), an Israeli clinical-stage cell therapy company, said on Monday t...
Eton Pharmaceuticals secures US patent for ET-600, protecting formulation through 2044
7 February 2025 - US pharmaceutical company Eton Pharmaceuticals (Nasdaq:ETON) announced on Friday that the United States Patent and Trademark Office has granted US Patent No. 12,214,010 for ET-600, a...
Bain Capital to acquire Mitsubishi Tanabe Pharma in USD3.3bn deal
7 February 2025 - Alternative investment firm Bain Capital announced on Friday that it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) in a carve-out transacti...